Identifier |
20180306_nanos_posters_161 |
Title |
Baseline Characteristics of LHON Subjects in the RESCUE and REVERSE Phase III Gene Therapy Trials |
Creator |
Mark Moster, Catherine Vignal, Nancy Newman, Alfredo Sadun, Patrick Yu-Wai-Man, Valerio Carelli, Thomas Klopstock, Adam Debusk, Robert Sergott, Molly Scannel Bryan, Jose-Alain Sahel, Barrett Katz, Scott Uretsky |
Subject |
Genetic Disease; Optic Neuropathy |
Description |
RESCUE and REVERSE are Phase‑ III, randomized, multicenter, double‑masked, sham‑ controlled trials of rAAV2/2-ND4, an intravitreally injected gene therapy for treatment of ND4‑ LHON. RESCUE subjects had vision loss for ≤6 months and REVERSE subjects from >6 months up to 1 year. |
Date |
2018-03 |
Language |
eng |
Format |
application/pdf |
Source |
2018 North American Neuro-Ophthalmology Society Annual Meeting |
Relation is Part of |
NANOS 2018: Poster Presentations |
Collection |
Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu |
Publisher |
Spencer S. Eccles Health Sciences Library, University of Utah |
Holding Institution |
North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416 |
Rights Management |
Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
ARK |
ark:/87278/s65q8w8p |
Context URL |
The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/ |
Contributor Primary |
Mark Moster |
Contributor Secondary |
Catherine Vignal, Nancy Newman, Alfredo Sadun, Patrick Yu-Wai-Man, Valerio Carelli, Thomas Klopstock, Adam Debusk, Robert Sergott, Molly Scannel Bryan, Jose-Alain Sahel, Barrett Katz, Scott Uretsky |
Setname |
ehsl_novel_nam |
ID |
1309581 |
Reference URL |
https://collections.lib.utah.edu/ark:/87278/s65q8w8p |